Editorial Comment: Matching-Adjusted Indirect Comparisons of Gemcitabine Intravesical System Vs. Novel Agents in Bacillus Calmette-Guérin-Unresponsive High-Risk Non-muscle Invasive Bladder Cancer
Fields of Study & Subjects
Bladder and Urothelial Cancer Treatments
Urinary Tract Infections Management
Urinary Bladder and Prostate Research
Publication details
- Journal / source
- JU Open Plus
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Volume
- 4
- Issue
- 5
- Publication date
- 1 May 2026
- Language
- EN